...
首页> 外文期刊>Haematologica >Detection of single and associated lesions of the Bcl-1, Bcl-2, Bcl-6, c-myc, p53 and p16 genes in B-cell non-Hodgkin's lymphomas: value of molecular analysis for a better assignment of the histologic subtype | Haematologica
【24h】

Detection of single and associated lesions of the Bcl-1, Bcl-2, Bcl-6, c-myc, p53 and p16 genes in B-cell non-Hodgkin's lymphomas: value of molecular analysis for a better assignment of the histologic subtype | Haematologica

机译:检测B细胞非霍奇金淋巴瘤中Bcl-1,Bcl-2,Bcl-6,c-myc,p53和p16基因的单个和相关病变:分子分析对更好地区分组织学亚型的价值血液学

获取原文
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND AND OBJECTIVE: Molecular genetic abnormalities have been frequently described in non-Hodgkin's lymphomas (NHL). These lesions have been associated with specific entities, allowing a better categorization of NHL. However, these abnormalities are not as specific as initially described and their association is still unknown. DESIGN AND METHODS: By Southern blot and polymerase chain reaction, we have simultaneously analyzed the proto-oncogenes Bcl-1, Bcl-2, Bcl-6, c-myc and MLL and the tumor suppressor genes p53 and p16, in 100 unselected B-cell NHL patients at diagnosis, to establish its incidence throughout the different NHL subtypes, defined both by Working Formulation and REAL classifications, and to assess the frequency of co-existence of two or more genetic lesions within each individual patient. RESULTS: Fifty two cases displayed some genetic abnormality. Bcl-1, altered in 12 cases, was highly specific to mantle cell lymphomas (57% of them), but 6 cases had a different histologic subtype. Bcl-2 was rearranged in 26 cases: 70% in follicular lymphomas (FL) and 20% in diffuse large cell lymphomas; these abnormalities were also present in other subtypes, i.e. marginal lymphomas (30%). Bcl-6 abnormalities were mostly found in diffuse large cell lymphomas (29%) but also found in other subgroups, like FL (14%). C-myc rearrangements were specific to Burkitt's lymphoma. MLL gene was always germline. Deletions and/or rearrangements of p53 and p16 genes were rare (4% and 8% of all cases, respectively). Finally, association of genetic lesions was a relatively common finding (13% of cases), especially in cases with adverse prognostic morphologies according to the REAL. INTERPRETATION AND CONCLUSIONS: Molecular abnormalities are frequent in NHL at diagnosis, not only as unique lesions but also associated. A relative high specificity of some alterations was seen, thereby contributing to a better assessment of the histological subtype.
机译:背景与目的:非霍奇金淋巴瘤(NHL)中经常描述分子遗传异常。这些病变与特定实体相关联,可以更好地分类NHL。但是,这些异常并不像最初描述的那样具体,它们的关联仍然未知。设计与方法:通过Southern印迹和聚合酶链反应,我们同时分析了100例未选择的B中的原癌基因Bcl-1,Bcl-2,Bcl-6,c-myc和MLL以及抑癌基因p53和p16。 -细胞性NHL患者在诊断时,要确定其在由工作配方和REAL分类定义的不同NHL亚型中的发生率,并评估每位患者中两种或多种遗传性病变共存的频率。结果:52例出现遗传异常。 Bcl-1在12例中发生了改变,对套细胞淋巴瘤具有高度特异性(其中57%),但是6例具有不同的组织学亚型。 Bcl-2基因重排26例:滤泡性淋巴瘤(FL)70%,弥漫性大细胞淋巴瘤20%;这些异常也存在于其他亚型,即边缘淋巴瘤(30%)中。 Bcl-6异常多见于弥漫性大细胞淋巴瘤(29%),也见于其他亚组,如FL(14%)。 C-myc重排特定于伯基特氏淋巴瘤。 MLL基因总是种系。 p53和p16基因的缺失和/或重排很少(分别占所有病例的4%和8%)。最后,遗传病变的关联是一个相对普遍的发现(占病例的13%),尤其是根据REAL的预后不良的病例。结论和结论:NHL在诊断时经常发生分子异常,不仅是独特的病变,而且是相关的。观察到一些改变的相对较高的特异性,从而有助于更好地评估组织学亚型。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号